Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Food & Beverages > Global Formulas for Special Medical Purposes for Diabetes Market Research Report 2025

Global Formulas for Special Medical Purposes for Diabetes Market Research Report 2025

Industry: Food & Beverages

Published: 2025-03-03

Pages: 91 Pages

Report ld: 4401661

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Formulas for Special Medical Purposes for Diabetes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.

North American market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Formulas for Special Medical Purposes for Diabetes include Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer, EnterNutr, Anhui New Health Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Formulas for Special Medical Purposes for Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Formulas for Special Medical Purposes for Diabetes.

The Formulas for Special Medical Purposes for Diabetes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Formulas for Special Medical Purposes for Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Formulas for Special Medical Purposes for Diabetes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Report Metric
Details
Report Title
Global Formulas for Special Medical Purposes for Diabetes Market Research Report 2025
Market Size Available for Years
2025-2031
Global Formulas for Special Medical Purposes for Diabetes Companies Covered
Abbott Laboratories
Nestlé S.A.
NUTRICIA
Fresenius
Ajinomoto
MeadJohnson
BOSSD
Bayer
EnterNutr
Anhui New Health Biotechnology
Bangsidi Biotechnology
Dongze Special Medical Food
Special Biotechnology
Haisike Pharmaceutical
Xi'an Libang Clinical Nutrition
Global Formulas for Special Medical Purposes for Diabetes Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Formulas for Special Medical Purposes for Diabetes Market, Segment by Type
Gel Food
Porous Food
Powdered Food
Pasty Food
Milky Food
Others
Global Formulas for Special Medical Purposes for Diabetes Market, Segment by Application
Hospital
Pharmacy
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Formulas for Special Medical Purposes for Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Formulas for Special Medical Purposes for Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Formulas for Special Medical Purposes for Diabetes Market Overview
    1.1 Product Definition
    1.2 Formulas for Special Medical Purposes for Diabetes by Type
        1.2.1 Global Formulas for Special Medical Purposes for Diabetes Market Value Comparison by Type (2024 VS 2031)
        1.2.2 Gel Food
        1.2.3 Porous Food
        1.2.4 Powdered Food
        1.2.5 Pasty Food
        1.2.6 Milky Food
        1.2.7 Others
    1.3 Formulas for Special Medical Purposes for Diabetes by Application
        1.3.1 Global Formulas for Special Medical Purposes for Diabetes Market Value by Application (2024 VS 2031)
        1.3.2 Hospital
        1.3.3 Pharmacy
        1.3.4 Others
    1.4 Global Formulas for Special Medical Purposes for Diabetes Market Size Estimates and Forecasts
        1.4.1 Global Formulas for Special Medical Purposes for Diabetes Revenue 2020-2031
        1.4.2 Global Formulas for Special Medical Purposes for Diabetes Sales 2020-2031
        1.4.3 Global Formulas for Special Medical Purposes for Diabetes Market Average Price (2020-2031)
    1.5 Assumptions and Limitations

2 Formulas for Special Medical Purposes for Diabetes Market Competition by Manufacturers
    2.1 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Manufacturers (2020-2025)
    2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Manufacturers (2020-2025)
    2.3 Global Formulas for Special Medical Purposes for Diabetes Average Price by Manufacturers (2020-2025)
    2.4 Global Key Players of Formulas for Special Medical Purposes for Diabetes, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Product Type & Application
    2.7 Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Date of Enter into This Industry
    2.8 Global Formulas for Special Medical Purposes for Diabetes Market Competitive Situation and Trends
        2.8.1 Global Formulas for Special Medical Purposes for Diabetes Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Formulas for Special Medical Purposes for Diabetes Players Market Share by Revenue
        2.8.3 Global Formulas for Special Medical Purposes for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Formulas for Special Medical Purposes for Diabetes Market Scenario by Region
    3.1 Global Formulas for Special Medical Purposes for Diabetes Market Size by Region: 2020 Versus 2024 Versus 2031
    3.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2020-2031
        3.2.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2020-2025
        3.2.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2026-2031
    3.3 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2020-2031
        3.3.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2020-2025
        3.3.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2026-2031
    3.4 North America Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
        3.4.1 North America Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2020 VS 2024 VS 2031
        3.4.2 North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2031)
        3.4.3 North America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2031)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
        3.5.1 Europe Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2020 VS 2024 VS 2031
        3.5.2 Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2031)
        3.5.3 Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2031)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Region
        3.6.1 Asia Pacific Formulas for Special Medical Purposes for Diabetes Market Size by Region: 2020 VS 2024 VS 2031
        3.6.2 Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Region (2020-2031)
        3.6.3 Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Region (2020-2031)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
        3.7.1 Latin America Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2020 VS 2024 VS 2031
        3.7.2 Latin America Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2031)
        3.7.3 Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2031)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
        3.8.1 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2020 VS 2024 VS 2031
        3.8.2 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2031)
        3.8.3 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2031)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

4 Segment by Type
    4.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2020-2031)
        4.1.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2020-2025)
        4.1.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2026-2031)
        4.1.3 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2020-2031)
    4.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2020-2031)
        4.2.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2020-2025)
        4.2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2026-2031)
        4.2.3 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2020-2031)
    4.3 Global Formulas for Special Medical Purposes for Diabetes Price by Type (2020-2031)

5 Segment by Application
    5.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2020-2031)
        5.1.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2020-2025)
        5.1.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2026-2031)
        5.1.3 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2020-2031)
    5.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2020-2031)
        5.2.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2020-2025)
        5.2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2026-2031)
        5.2.3 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2020-2031)
    5.3 Global Formulas for Special Medical Purposes for Diabetes Price by Application (2020-2031)

6 Key Companies Profiled
    6.1 Abbott Laboratories
        6.1.1 Abbott Laboratories Company Information
        6.1.2 Abbott Laboratories Description and Business Overview
        6.1.3 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.1.4 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.1.5 Abbott Laboratories Recent Developments/Updates
    6.2 Nestlé S.A.
        6.2.1 Nestlé S.A. Company Information
        6.2.2 Nestlé S.A. Description and Business Overview
        6.2.3 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.2.4 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.2.5 Nestlé S.A. Recent Developments/Updates
    6.3 NUTRICIA
        6.3.1 NUTRICIA Company Information
        6.3.2 NUTRICIA Description and Business Overview
        6.3.3 NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.3.4 NUTRICIA Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.3.5 NUTRICIA Recent Developments/Updates
    6.4 Fresenius
        6.4.1 Fresenius Company Information
        6.4.2 Fresenius Description and Business Overview
        6.4.3 Fresenius Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.4.4 Fresenius Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.4.5 Fresenius Recent Developments/Updates
    6.5 Ajinomoto
        6.5.1 Ajinomoto Company Information
        6.5.2 Ajinomoto Description and Business Overview
        6.5.3 Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.5.4 Ajinomoto Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.5.5 Ajinomoto Recent Developments/Updates
    6.6 MeadJohnson
        6.6.1 MeadJohnson Company Information
        6.6.2 MeadJohnson Description and Business Overview
        6.6.3 MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.6.4 MeadJohnson Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.6.5 MeadJohnson Recent Developments/Updates
    6.7 BOSSD
        6.7.1 BOSSD Company Information
        6.7.2 BOSSD Description and Business Overview
        6.7.3 BOSSD Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.7.4 BOSSD Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.7.5 BOSSD Recent Developments/Updates
    6.8 Bayer
        6.8.1 Bayer Company Information
        6.8.2 Bayer Description and Business Overview
        6.8.3 Bayer Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.8.4 Bayer Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.8.5 Bayer Recent Developments/Updates
    6.9 EnterNutr
        6.9.1 EnterNutr Company Information
        6.9.2 EnterNutr Description and Business Overview
        6.9.3 EnterNutr Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.9.4 EnterNutr Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.9.5 EnterNutr Recent Developments/Updates
    6.10 Anhui New Health Biotechnology
        6.10.1 Anhui New Health Biotechnology Company Information
        6.10.2 Anhui New Health Biotechnology Description and Business Overview
        6.10.3 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.10.4 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.10.5 Anhui New Health Biotechnology Recent Developments/Updates
    6.11 Bangsidi Biotechnology
        6.11.1 Bangsidi Biotechnology Company Information
        6.11.2 Bangsidi Biotechnology Description and Business Overview
        6.11.3 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.11.4 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.11.5 Bangsidi Biotechnology Recent Developments/Updates
    6.12 Dongze Special Medical Food
        6.12.1 Dongze Special Medical Food Company Information
        6.12.2 Dongze Special Medical Food Description and Business Overview
        6.12.3 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.12.4 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.12.5 Dongze Special Medical Food Recent Developments/Updates
    6.13 Special Biotechnology
        6.13.1 Special Biotechnology Company Information
        6.13.2 Special Biotechnology Description and Business Overview
        6.13.3 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.13.4 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.13.5 Special Biotechnology Recent Developments/Updates
    6.14 Haisike Pharmaceutical
        6.14.1 Haisike Pharmaceutical Company Information
        6.14.2 Haisike Pharmaceutical Description and Business Overview
        6.14.3 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.14.4 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.14.5 Haisike Pharmaceutical Recent Developments/Updates
    6.15 Xi'an Libang Clinical Nutrition
        6.15.1 Xi'an Libang Clinical Nutrition Company Information
        6.15.2 Xi'an Libang Clinical Nutrition Description and Business Overview
        6.15.3 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2020-2025)
        6.15.4 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product Portfolio
        6.15.5 Xi'an Libang Clinical Nutrition Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
    7.1 Formulas for Special Medical Purposes for Diabetes Industry Chain Analysis
    7.2 Formulas for Special Medical Purposes for Diabetes Raw Material Supply Analysis
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Formulas for Special Medical Purposes for Diabetes Production Mode & Process Analysis
    7.4 Formulas for Special Medical Purposes for Diabetes Sales and Marketing
        7.4.1 Formulas for Special Medical Purposes for Diabetes Sales Channels
        7.4.2 Formulas for Special Medical Purposes for Diabetes Distributors
    7.5 Formulas for Special Medical Purposes for Diabetes Customer Analysis

8 Formulas for Special Medical Purposes for Diabetes Market Dynamics
    8.1 Formulas for Special Medical Purposes for Diabetes Industry Trends
    8.2 Formulas for Special Medical Purposes for Diabetes Market Drivers
    8.3 Formulas for Special Medical Purposes for Diabetes Market Challenges
    8.4 Formulas for Special Medical Purposes for Diabetes Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Formulas for Special Medical Purposes for Diabetes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Formulas for Special Medical Purposes for Diabetes Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Formulas for Special Medical Purposes for Diabetes Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Formulas for Special Medical Purposes for Diabetes Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Formulas for Special Medical Purposes for Diabetes Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Formulas for Special Medical Purposes for Diabetes Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Formulas for Special Medical Purposes for Diabetes, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Product Type & Application
 Table 12. Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Formulas for Special Medical Purposes for Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Formulas for Special Medical Purposes for Diabetes as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Formulas for Special Medical Purposes for Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2020-2025) & (K Units)
 Table 18. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2020-2025)
 Table 19. Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2026-2031) & (K Units)
 Table 20. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2026-2031)
 Table 21. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2020-2025)
 Table 23. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2026-2031)
 Table 25. North America Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2025) & (K Units)
 Table 27. North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2026-2031) & (K Units)
 Table 28. North America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Formulas for Special Medical Purposes for Diabetes Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Formulas for Special Medical Purposes for Diabetes Sales (K Units) by Type (2020-2025)
 Table 51. Global Formulas for Special Medical Purposes for Diabetes Sales (K Units) by Type (2026-2031)
 Table 52. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2020-2025)
 Table 53. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2026-2031)
 Table 54. Global Formulas for Special Medical Purposes for Diabetes Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Formulas for Special Medical Purposes for Diabetes Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2020-2025)
 Table 57. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2026-2031)
 Table 58. Global Formulas for Special Medical Purposes for Diabetes Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Formulas for Special Medical Purposes for Diabetes Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Formulas for Special Medical Purposes for Diabetes Sales (K Units) by Application (2020-2025)
 Table 61. Global Formulas for Special Medical Purposes for Diabetes Sales (K Units) by Application (2026-2031)
 Table 62. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2020-2025)
 Table 63. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2026-2031)
 Table 64. Global Formulas for Special Medical Purposes for Diabetes Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Formulas for Special Medical Purposes for Diabetes Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2020-2025)
 Table 67. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2026-2031)
 Table 68. Global Formulas for Special Medical Purposes for Diabetes Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Formulas for Special Medical Purposes for Diabetes Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Laboratories Company Information
 Table 71. Abbott Laboratories Description and Business Overview
 Table 72. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product
 Table 74. Abbott Laboratories Recent Developments/Updates
 Table 75. Nestlé S.A. Company Information
 Table 76. Nestlé S.A. Description and Business Overview
 Table 77. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product
 Table 79. Nestlé S.A. Recent Developments/Updates
 Table 80. NUTRICIA Company Information
 Table 81. NUTRICIA Description and Business Overview
 Table 82. NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. NUTRICIA Formulas for Special Medical Purposes for Diabetes Product
 Table 84. NUTRICIA Recent Developments/Updates
 Table 85. Fresenius Company Information
 Table 86. Fresenius Description and Business Overview
 Table 87. Fresenius Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Fresenius Formulas for Special Medical Purposes for Diabetes Product
 Table 89. Fresenius Recent Developments/Updates
 Table 90. Ajinomoto Company Information
 Table 91. Ajinomoto Description and Business Overview
 Table 92. Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ajinomoto Formulas for Special Medical Purposes for Diabetes Product
 Table 94. Ajinomoto Recent Developments/Updates
 Table 95. MeadJohnson Company Information
 Table 96. MeadJohnson Description and Business Overview
 Table 97. MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. MeadJohnson Formulas for Special Medical Purposes for Diabetes Product
 Table 99. MeadJohnson Recent Developments/Updates
 Table 100. BOSSD Company Information
 Table 101. BOSSD Description and Business Overview
 Table 102. BOSSD Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BOSSD Formulas for Special Medical Purposes for Diabetes Product
 Table 104. BOSSD Recent Developments/Updates
 Table 105. Bayer Company Information
 Table 106. Bayer Description and Business Overview
 Table 107. Bayer Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bayer Formulas for Special Medical Purposes for Diabetes Product
 Table 109. Bayer Recent Developments/Updates
 Table 110. EnterNutr Company Information
 Table 111. EnterNutr Description and Business Overview
 Table 112. EnterNutr Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. EnterNutr Formulas for Special Medical Purposes for Diabetes Product
 Table 114. EnterNutr Recent Developments/Updates
 Table 115. Anhui New Health Biotechnology Company Information
 Table 116. Anhui New Health Biotechnology Description and Business Overview
 Table 117. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product
 Table 119. Anhui New Health Biotechnology Recent Developments/Updates
 Table 120. Bangsidi Biotechnology Company Information
 Table 121. Bangsidi Biotechnology Description and Business Overview
 Table 122. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product
 Table 124. Bangsidi Biotechnology Recent Developments/Updates
 Table 125. Dongze Special Medical Food Company Information
 Table 126. Dongze Special Medical Food Description and Business Overview
 Table 127. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product
 Table 129. Dongze Special Medical Food Recent Developments/Updates
 Table 130. Special Biotechnology Company Information
 Table 131. Special Biotechnology Description and Business Overview
 Table 132. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product
 Table 134. Special Biotechnology Recent Developments/Updates
 Table 135. Haisike Pharmaceutical Company Information
 Table 136. Haisike Pharmaceutical Description and Business Overview
 Table 137. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product
 Table 139. Haisike Pharmaceutical Recent Developments/Updates
 Table 140. Xi'an Libang Clinical Nutrition Company Information
 Table 141. Xi'an Libang Clinical Nutrition Description and Business Overview
 Table 142. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product
 Table 144. Xi'an Libang Clinical Nutrition Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Formulas for Special Medical Purposes for Diabetes Distributors List
 Table 148. Formulas for Special Medical Purposes for Diabetes Customers List
 Table 149. Formulas for Special Medical Purposes for Diabetes Market Trends
 Table 150. Formulas for Special Medical Purposes for Diabetes Market Drivers
 Table 151. Formulas for Special Medical Purposes for Diabetes Market Challenges
 Table 152. Formulas for Special Medical Purposes for Diabetes Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Formulas for Special Medical Purposes for Diabetes
 Figure 2. Global Formulas for Special Medical Purposes for Diabetes Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Formulas for Special Medical Purposes for Diabetes Market Share by Type: 2024 & 2031
 Figure 4. Gel Food Product Picture
 Figure 5. Porous Food Product Picture
 Figure 6. Powdered Food Product Picture
 Figure 7. Pasty Food Product Picture
 Figure 8. Milky Food Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Formulas for Special Medical Purposes for Diabetes Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Formulas for Special Medical Purposes for Diabetes Market Share by Application: 2024 & 2031
 Figure 12. Hospital
 Figure 13. Pharmacy
 Figure 14. Others
 Figure 15. Global Formulas for Special Medical Purposes for Diabetes Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Formulas for Special Medical Purposes for Diabetes Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Formulas for Special Medical Purposes for Diabetes Sales (2020-2031) & (K Units)
 Figure 18. Global Formulas for Special Medical Purposes for Diabetes Average Price (US$/Unit) & (2020-2031)
 Figure 19. Formulas for Special Medical Purposes for Diabetes Report Years Considered
 Figure 20. Formulas for Special Medical Purposes for Diabetes Sales Share by Manufacturers in 2024
 Figure 21. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Formulas for Special Medical Purposes for Diabetes Players: Market Share by Revenue in Formulas for Special Medical Purposes for Diabetes in 2024
 Figure 23. Formulas for Special Medical Purposes for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Formulas for Special Medical Purposes for Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2020-2031)
 Figure 26. North America Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2020-2031)
 Figure 27. United States Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2020-2031)
 Figure 30. Europe Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2020-2031)
 Figure 38. China Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Formulas for Special Medical Purposes for Diabetes by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Formulas for Special Medical Purposes for Diabetes by Type (2020-2031)
 Figure 57. Global Formulas for Special Medical Purposes for Diabetes Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Formulas for Special Medical Purposes for Diabetes by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Formulas for Special Medical Purposes for Diabetes by Application (2020-2031)
 Figure 60. Global Formulas for Special Medical Purposes for Diabetes Price (US$/Unit) by Application (2020-2031)
 Figure 61. Formulas for Special Medical Purposes for Diabetes Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed

Description

The global market for Formulas for Special Medical Purposes for Diabetes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.

North American market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Formulas for Special Medical Purposes for Diabetes include Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer, EnterNutr, Anhui New Health Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Formulas for Special Medical Purposes for Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Formulas for Special Medical Purposes for Diabetes.

The Formulas for Special Medical Purposes for Diabetes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Formulas for Special Medical Purposes for Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Formulas for Special Medical Purposes for Diabetes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Formulas for Special Medical Purposes for Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Formulas for Special Medical Purposes for Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Related Reports

Global Formulas for Special Medical Purposes for Diabetes Market Research Report 2024
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
Published: 2024-02-23
Pages: 97
USD 2900.00
(Single User License)
Global Formulas for Special Medical Purposes for Diabetes Market Insights, Forecast to 2030
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
Published: 2024-04-26
Pages: 117
USD 4900.00
(Single User License)
Formulas for Special Medical Purposes for Diabetes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 124
USD 3950.00
(Single User License)
Global Formulas for Special Medical Purposes for Diabetes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Formulas for Special Medical Purposes for Diabetes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 98
USD 4250.00
(Single User License)
Global Formulas for Special Medical Purposes for Diabetes Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Formulas for Special Medical Purposes for Diabetes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 170
USD 4900.00
(Single User License)
Global Formulas for Special Medical Purposes for Diabetes Market Research Report 2026
The global Formulas for Special Medical Purposes for Diabetes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 125
USD 2900.00
(Single User License)
Formulas for Special Medical Purposes for Diabetes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 122
USD 3950.00
(Single User License)

Global Formulas for Special Medical Purposes for Diabetes Market Research Report 2024
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
Published: 2024-02-23
Pages: 97
USD 2900.00 ()
Global Formulas for Special Medical Purposes for Diabetes Market Insights, Forecast to 2030
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
Published: 2024-04-26
Pages: 117
USD 4900.00 ()
Formulas for Special Medical Purposes for Diabetes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 124
USD 3950.00 ()
Global Formulas for Special Medical Purposes for Diabetes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Formulas for Special Medical Purposes for Diabetes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 98
USD 4250.00 ()
Global Formulas for Special Medical Purposes for Diabetes Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Formulas for Special Medical Purposes for Diabetes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 170
USD 4900.00 ()
Global Formulas for Special Medical Purposes for Diabetes Market Research Report 2026
The global Formulas for Special Medical Purposes for Diabetes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 125
USD 2900.00 ()
Formulas for Special Medical Purposes for Diabetes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 122
USD 3950.00 ()